findmyKOL
Clinical trialNCT02512458CompletedPhase 2Interventional

Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer

SponsorHellenic Cooperative Oncology GroupEnrollment60Bone Metastatic Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Eleni Efstathiou, MD,Ass. Prof

    Unit of Medical Oncology,Department of Clinical Theraputics,General Hospital of Athens "Alexandra"

    Study Chair

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Greece
  • Athens Medical Center, Dept of Medical Oncology

    Athens, Maroussi, Greece

  • Euromedica General Clinic of Thessaloniki

    Thessaloniki, Thessaloniki, Greece

  • Agii Anargiri Cancer Hospital, 3rd Dept of Medical Oncology

    Athens, Greece

  • General Hospital of Athens "alexandra", Unit of Medical Oncology, Dept of Clinical Therapeutics

    Athens, Greece

  • Ioannina University Hospital, Dept of Medical Oncology

    Ioannina, Greece

  • Papageorgiou General Hospital, Dept of Medical Oncology

    Thessaloniki, Greece

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Oct 2015
Primary completion
31 Dec 2019
Completion
27 Dec 2019
Last update posted
10 Feb 2020
Registered enrollment
60
Registry id
NCT02512458

Cross-registrations

EU-CTR / CTIS (EudraCT)2014-004485-21

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.